CGTLive®’s Weekly Rewind – December 20, 2024
Review top news and interview highlights from the week ending December 20, 2024.
CGTLive® Presents: ImmunoLogic, A Video Podcast With Joseph Fraietta, PhD
Hosted by Joseph Fraietta, PhD, ImmunoLogic will be tailored for an audience fluent in the language of medicine and biotechnology, offering data-driven insights while maintaining accessibility.
Around the Helix: Cell and Gene Therapy Company Updates – December 18, 2024
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Bristol Myers Squibb and 2seventy bio's CAR-T Ide-Cel Effects Responses in CNS-Involved R/R Multiple Myeloma
Real-world data showed ide-cel was active in patients with central nervous system manifestations of multiple myeloma.
CGTLive®’s Weekly Rewind – December 13, 2024
Review top news and interview highlights from the week ending December 13, 2024.
Cilta-Cel Boosts MRD Negativity Rates Compared to Standard of Care Therapy in New Multiple Myeloma Data
The results come from patients with lenalidomide-refractory MM treated in the CARTITUDE-4 trial after 1 to 3 lines of prior therapy.
